CollPlant is a company headquartered in Israel.
CollPlant develops recombinant human collagen (rhCollagen) technology and products for regenerative medicine, including 3D bioprinting bioinks, medical aesthetics such as dermal fillers and implants, and tissue regeneration therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.